Trump, Harris plans on drug costs, abortion, Obamacare differ
From CNBC: 2024-10-19 08:00:01
President Donald Trump and Democratic nominee Kamala Harris are highlighting key health care issues ahead of the upcoming presidential election, including prescription drug costs and health care affordability in the U.S. Despite promises to make care more affordable, the candidates have different approaches. Harris supports expanding Medicare and the Affordable Care Act, while Trump aims to slash federal health spending. The U.S. currently spends over $4 trillion annually on health care but has poorer outcomes than other developed nations, such as high maternal and infant death rates. Harris plans to lower drug prices, including a $35 monthly limit on insulin costs and a $2,000 annual cap on drug spending. Harris aims to continue the Biden administration’s efforts to lower health care costs, including expanding Medicare drug price negotiations with manufacturers. Yet, some Republican critics argue these efforts could harm innovation and reduce the number of cures. Harris plans to make ACA subsidies permanent and work to expand Medicaid coverage in states that haven’t already done so. Trump has implemented temporary measures to lower drug prices, such as importing medication from Canada and capping insulin costs. However, his administration’s actions have faced opposition and some policies have been rescinded. Both candidates acknowledge the challenges in reforming the complex U.S. health care system, which is heavily entrenched with various stakeholders, including doctors, insurers, and pharmaceutical companies. During the election, health care is a key issue for voters, with concerns about the affordability of treatments and access to care driving the debate. Look to the upcoming election for potential changes in health care policy and their impact on patient outcomes and costs.
Read more at CNBC: Trump, Harris plans on drug costs, abortion, Obamacare differ